Abstract:Overview: In this study, the physical and chemical properties of curcumin are extensively examined when it is incorporated into liposome nanoparticles, to enhance its therapeutic potency and bioavailability. Curcumin, a plant-derived polyphenol, has garnered attention for its anti-inflammatory, antioxidant, and anti-cancer activities. However, its clinical utility is hindered by several limitations, including poor water solubility, inadequate absorption, and rapid metabolism. By leveraging the potential of liposome nanoparticles to improve drug delivery and efficacy, this research aims to overcome these obstacles and unlock the full therapeutic potential of curcumin. Methods: Curcumin-loaded liposome nanoparticles (CLLNs) were fabricated employing a thin-film hydration method, after sonication. The physicochemical attributes of CLLNs were subsequently characterized, encompassing particle size and zeta potential assessment utilizing dynamic light scattering (DLS), encapsulation efficiency (EE%) and drug loading efficiency (DLE%) determination through high-performance liquid chromatography (HPLC), investigation of in vitro drug release patterns in simulated biological fluids. Results: The CLLNs optimized in this study had a mean particle diameter of less than 250 nm and a negative surface charge, implying good stability and potential for cellular uptake. The encapsulation efficiency and drug loading efficiency were both found to be high, indicating that curcumin was effectively loaded into the liposomes. In vitro release testing showed a sustained release pattern of curcumin from the CLLNs. Conclusion: The research offered important observations about the advantageous physicochemical features of curcumin-loaded liposome nanoparticles, highlighting their potential as a cutting-edge delivery system for curcumin. The study demonstrated that CLLNs have high encapsulation and drug loading efficiencies, as well as controlled release and improved stability, which suggests their ability to enhance the therapeutic benefits of curcumin. These findings set the stage for future in vivo and clinical trials to fully investigate the potential of CLLNs in medical applications.

Galactosylated Chitosan-Polycaprolactone Nanoparticles For Hepatocyte-Targeted Delivery Of Curcumin

Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma

Synthesis and in Vitro/in Vivo Anti-Cancer Evaluation of Curcumin-Loaded Chitosan/poly(butyl Cyanoacrylate) Nanoparticles.

Curcumin-loaded Galactosylated BSA Nanoparticles As Targeted Drug Delivery Carriers Inhibit Hepatocellular Carcinoma Cell Proliferation and Migration.

Linolenic Acid-Modified PEG-PCL Micelles for Curcumin Delivery

Glycyrrhizin-modified O-carboxymethyl Chitosan Nanoparticles As Drug Vehicles Targeting Hepatocellular Carcinoma.

Galactosamine-modified PEG-PLA/TPGS Micelles for the Oral Delivery of Curcumin.

Curcumin-loaded pH-sensitive carboxymethyl chitosan nanoparticles for the treatment of liver cancer

Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma

Y-shaped Biotin-Conjugated Poly (ethylene Glycol)-Poly (Epsilon-Caprolactone) Copolymer for the Targeted Delivery of Curcumin.

Novel Amphiphilic Rhamnogalacturonnan I-based Nanomicelles for Targeted Delivery of Curcumin to Hepatocellular Carcinoma Cells

Biocompatible PAMAM‐PLGA‐PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies

Nanoparticles Based on Chitosan Hydrochloride/hyaluronic Acid/peg Containing Curcumin: in Vitro Evaluation and Pharmacokinetics in Rats

Efficient delivery of curcumin by functional solid lipid nanoparticles with promoting endosomal escape and liver targeting properties

Preparation and characterization of curcumin-loaded methoxy poly(ethylene glycol)-block-poly(γ-cholesterol-l-glutamate) nanoparticles

Preparation and Evaluation of N-Caproyl Chitosan Nanoparticles Surface Modified with Glycyrrhizin for Hepatocyte Targeting

Effective Co-Delivery of Doxorubicin and Curcumin Using a Glycyrrhetinic Acid-Modified Chitosan-Cystamine-poly(ε-caprolactone) Copolymer Micelle for Combination Cancer Chemotherapy.

Elaboration and Characterization of Curcumin-Loaded Tri-CL-mPEG Three-Arm Copolymeric Nanoparticles by a Microchannel Technology

Novel Star-Type Methoxy-Poly(ethylene Glycol) (Peg)–poly(ε-Caprolactone) (PCL) Copolymeric Nanoparticles for Controlled Release of Curcumin

Glycyrrhetinic Acid-Modified Chitosan/poly(ethylene Glycol) Nanoparticles for Liver-Targeted Delivery

Studying the Characteristics of Curcumin-Loaded Liposomal Nanoparticles